Difference between toxicities of iron oxide magnetic nanoparticles with various surface-functional groups against human normal fibroblasts and fibrosarcoma cells

Materials

Volumn 6, Issue 10, 2013, Pages 4689-4706

  Yang, Won Jun ^a   Lee, Jong Ho ^a   Hong, Seong Cheol ^a   Lee, Jaewook ^a   Lee, Jaebeom ^a   Han, Dong Wook ^a  

^a Pusan National University   (South Korea)

Author keywords

Biocompatibility; Cancer cell; Magnetic nanoparticles; Normal cells; Surface functionalization

Indexed keywords

3-AMINOPROPYLTRIMETHOXYSILANE; CANCER CELLS; CRITICAL DETERMINANT; FUNCTIONALIZED SURFACES; MAGNETIC NANO-PARTICLES; MAGNETIC NANOPARTI CLES (MNPS); SURFACE FUNCTIONALIZATION; TETRAETHYL ORTHOSILICATES;

BIOCOMPATIBILITY; CELL CULTURE; CYTOTOXICITY; DISEASES; DRUG DELIVERY; FIBROBLASTS; FUNCTIONAL GROUPS; NANOPARTICLES;

TOXICITY;

EID: 84888771729     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma6104689     Document Type: Article

References (49)

1. Frey, N.A.; Peng, S.; Cheng, K.; Sun, S. Magnetic nanoparticles: Synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem. Soc. Rev. 2009, 38, 2532-2542.
2. Gao, J.; Gu, H.; Xu, B. Multifunctional magnetic nanoparticles: Design, synthesis, and biomedical applications. Acc. Chem. Res. 2009, 42, 1097-1107.
3. Frimpong, R.A.; Hilt, J.Z. Magnetic nanoparticles in biomedicine: Synthesis, functionalization and applications. Nanomedicine 2010, 5, 1401-1414.
4. Lee, J.; Kim, H.Y.; Zhou, H.; Hwang, S.; Koh, K.; Han, D.-W.; Lee, J. Green synthesis of phytochemical-stabilized Au nanoparticles under ambient conditions and their biocompatibility and antioxidative activity. J. Mater. Chem. 2011, 21, 13316-13326.
5. Granitzer, P.; Rumpf, K. Magnetic nanoparticles embedded in a silicon matrix. Materials 2011, 4, 908-928.
6. Yu, M.K.; Park, J.; Jon, S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2012, 2, 3-44.
7. Wahajuddin; Arora, S. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers. Int. J. Nanomedicine 2012, 7, 3445-3471.
8. Auffan, M.; Rose, J.; Bottero, J.Y.; Lowry, G.V.; Jolivet, J.P.; Wiesner, M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 2009, 4, 634-641.
9. Nel, A.; Xia, T.; Mädler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627.
10. Murphy, C.J.; Gole, A.M.; Stone, J.W.; Sisco, P.N.; Alkilany, A.M.; Goldsmith, E.C.; Baxter, S.C. Gold nanoparticles in biology: Beyond toxicity to cellular imaging. Acc. Chem. Res. 2008, 41, 1721-1730.
11. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 2009, 38, 1759-1782.
12. Vega-Villa, K.R.; Takemoto, J.K.; Yáñez, J.A.; Remsberg, C.M.; Forrest, M.L.; Davies, N.M. Clinical toxicities of nanocarrier systems. Adv. Drug Deliv. Rev. 2008, 60, 929-938.
13. Neuberger, T.; Schopf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293, 483-496.
14. Mbeh, D.A.; França, R.; Merhi, Y.; Zhang, X.F.; Veres, T.; Sacher, E.; Yahia, L. In vitro biocompatibility assessment of functionalized magnetite nanoparticles: Biological and cytotoxicological effects. J. Biomed. Mater. Res. A 2012, 100, 1637-1646.
15. Novotna, B.; Jendelova, P.; Kapcalova, M.; Rossner, P., Jr.; Turnovcova, K.; Bagryantseva, Y.; Babic, M.; Horak, D.; Sykova, E. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol. Lett. 2012, 210, 53-63.
16. Singh, N.; Jenkins, G.J.; Nelson, B.C.; Marquis, B.J.; Maffeis, T.G.; Brown, A.P.; Williams, P.M.; Wright, C.J.; Doak, S.H. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012, 33, 163-170.
17. Kumari, A.; Kumar, V.; Yadav, S.K. Therapeutic nanoparticles and associated toxicity. Curr. Nanosci. 2011, 7, 389-395.
18. Mahmoudi, M.; Laurent, S.; Shokrgozar, M.A.; Hosseinkhani, M. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: Cell "vision" versus physicochemical properties of nanoparticles. ACS Nano 2011, 5, 7263-7276.
19. Sharifi, S.; Behzadi, S.; Laurent, S.; Forrest, M.L.; Stroeve, P.; Mahmoudi, M. Toxicity of nanomaterials. Chem. Soc. Rev. 2012, 41, 2323-2343.
20. Hong, S.C.; Lee, J.H.; Lee, J.; Kim, H.Y.; Park, J.Y.; Cho, J.; Lee, J.; Han, D.-W. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int. J. Nanomedicine 2011, 6, 3219-3231.
21. Zhang, F.; Wang, C.C. Fabrication of one-dimensional iron oxide/silica nanostructures with high magnetic sensitivity by dipole-directed self-assembly J. Phys. Chem. C 2008, 112, 15151-15156.
22. Bucak, S.; Yavuztürk, B.; Sezer, A.D. Magnetic nanoparticles: synthesis, surface modifications and application in drug delivery. In Recent Advances in Novel Drug Carrier Systems, 1st ed.; Ali, D.S., Ed.; InTech: Rijeka, Croatia, 2012; Chapter 7, pp. 165-200.
23. Karlsson, H.L.; Cronholm, P.; Gustafsson, J.; Möller, L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21, 1726-1732.
24. Rivera, G.P.; Huhn, D.; del Mercato, L.L.; Sasse, D.; Parak, W.J. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacol. Res. 2010, 62, 115-125.
25. Bhattacharjee, S.; de Haan, L.H.; Evers, N.M.; Jiang, X.; Marcelis, A.T.; Zuilhof, H.; Rietjens, I.M.; Alink, G.M. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol. 2011, 7, doi:10.1186/1743-8977-7-25.
26. Kai, W.; Xiaojun, X.; Ximing, P.; Zhenqing, H.; Qiqing, Z. Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells. Nanoscale Res. Lett. 2011, 6, doi:10.1186/1556-276X-6-480.
27. Blank, F.; Gerber, P.; Rothen-Rutishauser, B.; Sakulkhu, U.; Salaklang, J.; de Peyer, K.; Gehr, P.; Nicod, L.P.; Hofmann, H.; Geiser, T.; Petri-Fink, A.; von Garnier, C. Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011, 5, 606-621.
28. Yu, M.; Huang, S.; Yu, K.J.; Clyne, A.M. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 2012, 13, 5554-5570.
29. Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of nanoparticles. Small 2008, 4, 26-49.
30. Gupta, A.K.; Wells, S. Surface-modified superparamagnetic nanoparticles for drug delivery: Preparation, characterization, and cytotoxicity studies. IEEE Trans. Nanobiosci. 2004, 3, 66-73.
31. Hoskins, C.; Cuschieri, A.; Wang, L. The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J. Nanobiotechnol. 2012, 10, doi:10.1186/1477-3155-10-15.
32. Singh, N.; Jenkins, G.J.; Asadi, R.; Doak, S.H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010, 1, doi:10.3402/nano.v1i0.5358.
33. Bhattacharya, D.; Sahu, S.K.; Banerjee, I.; Das, M.; Mishra, D.; Maiti, T.K.; Pramanik, P. Synthesis, characterization, and in vitro biological evaluation of highly stable diversely functionalized superparamagnetic iron oxide nanoparticles. J. Nanopart. Res. 2011, 13, 4173-4188.
34. Vácha, R.; Martinez-Veracoechea, F.J.; Frenkel, D. Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett. 2011, 11, 5391-5395.
35. Atabaev, T.Sh.; Lee, J.H.; Han, D.-W.; Hwang, Y.-H.; Kim, H.-K. Cytotoxicity and cell imaging potentials of submicron color-tunable yttria particles. J. Biomed. Mater. Res. A 2012, 100, 2287-2294.
36. Chithrani, B.D.; Chan, W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7, 1542-1550.
37. Jiang, W.; Kim, B.Y.; Rutka, J.T.; Chan, W.C. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3, 145-150.
38. Atabaev, T.Sh.; Jin, O.S.; Lee, J.H.; Han, D.-W.; Vu, H.H.T.; Hwang, Y.-H.; Kim, H.-K. Facile synthesis of bifunctional silica-coated core-shell Y2O3:Eu3+, Co2+ composite particles for biomedical applications. RSC Adv. 2012, 2, 9495-9501.
39. Sohaebuddin, S.K.; Thevenot, P.T.; Baker, D.; Eaton, J.W.; Tang, L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol. 2010, 7, doi:10.1186/1743-8977-7-22.
40. Park, K.S.; Lee, H.S.; Kim, Y.S.; Kang, T.M.; Lee, J.H.; Joh, J.W.; Kim, S.J. Improved quantification of islet transplants by magnetic resonance imaging with Resovist. Pancreas 2011, 40, 911-919.
41. Wang, S.; Fang, J.; Zhang, T.; Wang, B.; Chen, J.; Li, X.; Zhang, S.; Zhang, W. Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells. J. Neurooncol. 2011, 105, 67-75.
42. Mahmoudi, M.; Sant, S.; Wang, B.; Laurent, S.; Sen, T. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 2011, 63, 24-46.
43. Lin, M.M.; Kim, D.K.; El Haj, A.J.; Dobson, J. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE Trans. Nanobiosci. 2008, 7, 298-305.
44. Bae, J.E.; Huh, M.I.; Ryu, B.K.; Do, J.Y.; Jin, S.U.; Moon, M.J.; Jung, J.C.; Chang, Y.; Kim, E.; Chi, S.G.; et al. The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 2011, 32, 9401-9414.
45. Rossi, L.M.; Quach, A.D.; Rosenzweig, Z. Glucose oxidase-magnetite nanoparticle bioconjugate for glucose sensing. Anal. Bioanal. Chem. 2004, 380, 606-613.
46. Blazer-Yost, B.L.; Banga, A.; Amos, A.; Chernoff, E.; Lai, X.; Li, C.; Mitra, S.; Witzmann, F.A. Effect of carbon nanoparticles on renal epithelial cell structure, barrier function, and protein expression. Nanotoxicology 2011, 5, 354-371.
47. Singh, N.P.; McCoy, M.T.; Tice, R.R.; Schneider, E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175, 184-191.
48. Cemeli, E.; Anderson, D. Mechanistic investigation of ROS-induced DNA damage by oestrogenic compounds in lymphocytes and sperm using the comet assay. Int. J. Mol. Sci. 2011, 12, 2783-2796.
49. Klarić, M.S.; Darabos, D.; Rozgaj, R.; Kasuba, V.; Pepeljnjak, S. Beauvericin and ochratoxin A genotoxicity evaluated using the alkaline comet assay: Single and combined genotoxic action. Arch. Toxicol. 2010, 84, 641-650.